The synthesis of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex multi-step synthetic process. Early routes focused on protein fragment coupling, utilizing solid-phase https://lawsonjkre615094.life3dblog.com/39223007/creation-and-investigation-implementations-of-retatrutide